Anosmia Clinical Trial - NAC for Head Trauma-induced Anosmia

Status Terminated

Clinical Trial Summary

This study will compare administration of N-Acetyl Cysteine (NAC) versus placebo for the treatment of olfactory loss due to head injury. The hypothesis is that treatment with NAC acutely after head injury will result in improved olfactory function

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03680911
Study type	Interventional
Source	University of Miami
Contact
Status	Terminated
Phase	Phase 3
Start date	October 12, 2018
Completion date	January 7, 2020

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04964414` - Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19	Phase 1/Phase 2
Completed	`NCT05445921` - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction	Phase 1/Phase 2
Completed	`NCT05812209` - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Withdrawn	`NCT02179554` - Does Cardiopulmonary Bypass Change Olfaction?
Completed	`NCT04957563` - Clinical Utility of Olfactory Rehabilitation: Treatment for Pacients With Neurosensorial Anosmia	N/A
Completed	`NCT04657809` - Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia	Phase 2
Completed	`NCT04853836` - Olfactory Disfunction and Co-ultraPEALut	Phase 4
Recruiting	`NCT05040659` - Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
Recruiting	`NCT05562050` - Characteristics of the Anosmic Olfactory Mucosa
Completed	`NCT05152030` - The Clinical Applicability of the 'TIB' Olfactory Test Device
Recruiting	`NCT05384561` - Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19	N/A
Enrolling by invitation	`NCT04764981` - Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)	N/A
Withdrawn	`NCT04408391` - Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia
Completed	`NCT04361474` - Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity	Phase 3
Completed	`NCT03990766` - Smell Changes & Efficacy of Nasal Theophylline	Phase 2
Completed	`NCT04797936` - BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19	Phase 4
Recruiting	`NCT04528329` - Anosmia and / or Ageusia and Early Corticosteroid Use	Phase 4
Completed	`NCT04789499` - Smell in Covid-19 and Efficacy of Nasal Theophylline	Phase 2
Recruiting	`NCT04384042` - Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
Completed	`NCT04390165` - Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study